Showing results (231-240 of 274) with videos related to
Sort By:
Pageof 28
Leukemia|April 14, 2000
Prognostic factors in infants with acute myeloid leukemiaC H Pui, S C Raimondi, D K Srivastava, et al.Leukemia|March 13, 2001
Second malignancy after treatment of childhood acute myeloid leukemiaW Leung, R C Ribeiro, M Hudson, et al.Clinical Pharmacology and Therapeutics|October 29, 2010
Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemiaN Pottier, S W Paugh, C Ding, et al.Clinical Pharmacology and Therapeutics|January 29, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingM V Relling, E E Gardner, W J Sandborn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and XC H Pui, R K Dodge, A T Look, et al.Leukemia|February 1, 1992
Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study XC H Pui, J V Simone, M L Hancock, et al.Clinical Pharmacology and Therapeutics|September 13, 2016
An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic LeukemiaW Stock, B Diouf, K R Crews, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
In vivo biotherapy of HL-60 myeloid leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptorJ P Perentesis, R Gunther, B Waurzyniak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapyW L Furman, D L Fairclough, R D Huhn, et al.The New England Journal of Medicine|December 12, 1991
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemiaC H Pui, R C Ribeiro, M L Hancock, et al.Pageof 28